Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pear Therapeutics (PEAR)
NASDAQ:PEAR
Pear Therapeutics (PEAR) Financial Statements
0 Followers
Pear Therapeutics Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 2.56M | $ 4.08M | $ 3.30M | $ 2.75M | $ 1.32M |
| Gross Profit | $ 820.00K | $ 1.53M | $ 896.00K | $ 1.27M | $ -328.00K |
| EBIT | $ -29.16M | $ -26.63M | $ -32.82M | $ -34.74M | $ -34.23M |
| EBITDA | $ -27.63M | $ -25.16M | $ -31.42M | $ -33.45M | $ -33.49M |
| Net Income Common Stockholders | $ -26.37M | $ -30.72M | $ 5.46M | $ -23.86M | $ 18.75M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 59.27M | $ 83.62M | $ 107.11M | $ 137.40M | $ 174.57M |
| Total Assets | $ 95.13M | $ 119.73M | $ 142.52M | $ 172.09M | $ 197.16M |
| Total Debt | $ 37.61M | $ 38.06M | $ 38.39M | $ 38.63M | $ 26.99M |
| Net Debt | $ -21.66M | $ -45.56M | $ -68.72M | $ -98.78M | $ -147.58M |
| Total Liabilities | $ 64.54M | $ 67.49M | $ 63.48M | $ 102.58M | $ 106.73M |
| Stockholders Equity | $ 30.59M | $ 52.25M | $ 79.04M | $ 69.51M | $ 90.43M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -25.35M | $ -23.85M | $ -30.96M | $ -37.21M | $ -42.10M |
| Operating Cash Flow | $ -24.28M | $ -23.27M | $ -29.64M | $ -36.71M | $ -39.84M |
| Investing Cash Flow | $ 11.93M | $ 22.42M | $ -307.00K | $ -43.50M | $ -1.75M |
| Financing Cash Flow | $ 961.00K | $ 358.00K | $ 761.00K | $ 75.00K | $ 147.98M |
Pear Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.